FDA Webinar: Webinar Draft GFI On Rheumatoid Arthritis - Developing Drug Products For Treatment; Availability – July 25, 2013
On July 25, 2013, FDA presented a webinar on a new draft guidance entitled "Draft Guidance For Industry On Rheumatoid Arthritis - Developing Drug Products For Treatment; Availability."
The webinar provided an opportunity to learn about the guidance from individuals involved in its preparation. It was also intended to encourage the submission of questions or comments while the guidance is still in draft form.
Questions may be submitted to docket so that they can be formally processed by FDA.
DRAFT GFI:
FR NOTICE
Date FR NOA: 05/31/2013
Comment Period Closes: 07/30/2013
CONTACTS:
Nikolay Nikolov, MD
Medical Officer
Division Of Pulmonary, Allergy, And Rheumatology Products
Center for Drug Evaluation and Research (CDER)
White Oak, Bldg 22, Room 3335
301-796-5281
Presentation Information
ResourcesForYou
Archive of Past Webinars: http://www.fda.gov/Training/GuidanceWebinars/default.htm
If you have never attended a Connect Pro meeting before, please test your connection before the lecture by following this link: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm